Development and Validation of a Clinical Polygenic Risk Score to Predict Breast Cancer Risk

PURPOSE: Women with a family history of breast cancer are frequently referred for hereditary cancer genetic testing, yet < 10% are found to have pathogenic variants in known breast cancer susceptibility genes. Large-scale genotyping studies have identified common variants (primarily single-nucleo...

Descripción completa

Detalles Bibliográficos
Autores principales: Hughes, Elisha, Tshiaba, Placede, Gallagher, Shannon, Wagner, Susanne, Judkins, Thaddeus, Roa, Benjamin, Rosenthal, Eric, Domchek, Susan, Garber, Judy, Lancaster, Johnathan, Weitzel, Jeffrey, Kurian, Allison W., Lanchbury, Jerry S., Gutin, Alexander, Robson, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2020
Materias:
Original Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446363/
https://www.ncbi.nlm.nih.gov/pubmed/32923876
http://dx.doi.org/10.1200/PO.19.00360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446363/
https://www.ncbi.nlm.nih.gov/pubmed/32923876
http://dx.doi.org/10.1200/PO.19.00360

Ejemplares similares